Early pregnancy following multidrug regimen chemotherapy in a gestational trophoblastic neoplasia patient: A case report

被引:0
作者
Niu, Gang [1 ]
Yuan, Lin-Jing [1 ]
Gong, Feng-Qiu [2 ]
Yang, Juan [1 ]
Zhu, Cai-Xia [1 ]
Shen, Hong-Wei [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gynecol & Obstet, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China
关键词
5-fluorouracil; actinomycin-D; chemotherapy; gestation; gestational trophoblastic neoplasia; REPRODUCTIVE OUTCOMES; DISEASE; ACTINOMYCIN;
D O I
10.1097/MD.0000000000009221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale:Gestational trophoblastic neoplasia is a group of rare tumors that can be cured using chemotherapy. The use of artificial contraception for at least 1 year is recommended not only due to the high recurrence rate in the first year after treatment, but also because of the unclear genetic toxic effects of multidrug regimen chemotherapy on reproductive cells. There is no consensus about the contraception duration, but most patients want to have children.Patient concerns:This case involved a 33-year-old female suffering from gestational trophoblastic neoplasia and 5-fluorouracil + actinomycin-D chemotherapy. She became pregnant 1 month after finishing the chemotherapy.Diagnosis:Gestational trophoblastic neoplasia.Interventions:No treatment during pregnancy.Outcomes:The patient had a full-term normal delivery, and the baby showed normal development and growth after a follow-up of 48 months.Lessons:Pregnancy soon after chemotherapy can be viable with rigorous prenatal care.
引用
收藏
页数:3
相关论文
共 11 条
[1]   Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia [J].
Even, C. ;
Pautier, P. ;
Duvillard, P. ;
Floquet, A. ;
Kerbrat, P. ;
Troalen, F. ;
Rey, A. ;
Balleyguier, C. ;
Tazi, Y. ;
Leary, A. ;
Augereau, P. ;
Morice, P. ;
Droz, J. -P. ;
Fizazi, K. ;
Lhomme, C. .
EUROPEAN JOURNAL OF CANCER, 2014, 50 (12) :2082-2089
[2]  
Gadducci A, 2016, ANTICANCER RES, V36, P3477
[3]   Reproductive outcomes after hydatiform mole and gestational trophoblastic neoplasia [J].
Gadducci, Angiolo ;
Lanfredini, Nora ;
Cosio, Stefania .
GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (09) :673-678
[4]   Pregnancy after EMA/CO for gestational trophoblastic disease: a report from The Netherlands [J].
Lok, CAR ;
van der Houwen, C ;
ten Kate-Booij, MJ ;
van Eijkeren, MA ;
Ansink, AC .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2003, 110 (06) :560-566
[5]   5-Fluorouracil: Mechanisms of action and clinical strategies [J].
Longley, DB ;
Harkin, DP ;
Johnston, PG .
NATURE REVIEWS CANCER, 2003, 3 (05) :330-338
[6]   ACTINOMYCIN AND DNA-TRANSCRIPTION [J].
SOBELL, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (16) :5328-5331
[7]   Gestational trophoblastic disease [J].
Tse, K. Y. ;
Ngan, Hextan Y. S. .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2012, 26 (03) :357-370
[8]  
Vargas R, 2014, J REPROD MED, V59, P188
[9]   Comparison of MACT and 5Fu+ACT-D chemotherapy regimens in the treatment of low-risk gestational trophoblastic neoplasia [J].
Wang, Yu ;
Miao, Jin-wei ;
Wang, Tong ;
Wang, Yan ;
Wu, Yu-mei ;
Kong, Wei-min ;
Su, Li ;
Duan, Wei .
JOURNAL OF CHEMOTHERAPY, 2016, 28 (02) :135-139
[10]  
Williams J, 2014, J REPROD MED, V59, P248